Mechanism of inhibition of the plasma membrane Ca2+-ATPase by barbiturates

Danuta Kosk-Kosicka, Ioulia V Fomitcheva, Maria M. Lopez

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We have demonstrated that sodium pentobarbital inhibited the activation of the human red blood cell plasma membrane Ca2+-ATPase produced by dimerization of enzyme monomers or by calmodulin binding to enzyme monomers. The effects of the barbiturate were dose-dependent. Both Vmax and Ca2+ affinity were reduced. The Ca2+-ATPase activity of the dimeric enzyme was distinctly less sensitive with respect to the effective inhibitory concentrations of pentobarbital and to the rate of onset of inhibition than was the calmodulin-dependent activation of enzyme monomers. Temperature dependence of the inhibition was in agreement with direct, nonpolar interactions of pentobarbital with a water-exposed nonpolar patch on the surface of this transmembrane protein. The barbiturate prevented the increase of intrinsic tryptophan fluorescence associated with substrate Ca2+ binding to the enzyme dimer. On the basis of the barbiturate effects we propose a model for the action of detergent-like compounds on the enzyme. They inhibit Ca2+-ATPase activity by binding to a nonpolar patch on the water-exposed dimerization surface of the enzyme monomer, part of which is also the binding site for calmodulin. The model assumes that their binding to the nonpolar patch on the monomer interferes with dimerization and weakens but does not prohibit calmodulin binding, whose activation of the enzyme is then submaximal. The model should be applicable to other proteins as the two activation pathways studied have been demonstrated for various enzymes.

Original languageEnglish (US)
Pages (from-to)900-905
Number of pages6
JournalBiochemistry
Volume35
Issue number3
StatePublished - Jan 23 1996
Externally publishedYes

Fingerprint

Barbiturates
Calcium-Transporting ATPases
Cell membranes
Cell Membrane
Calmodulin
Enzymes
Dimerization
Pentobarbital
Monomers
Enzyme Activation
Chemical activation
Water
Tryptophan
Detergents
Membrane Proteins
Erythrocytes
Fluorescence
Binding Sites
Dimers
Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

Mechanism of inhibition of the plasma membrane Ca2+-ATPase by barbiturates. / Kosk-Kosicka, Danuta; Fomitcheva, Ioulia V; Lopez, Maria M.

In: Biochemistry, Vol. 35, No. 3, 23.01.1996, p. 900-905.

Research output: Contribution to journalArticle

Kosk-Kosicka, D, Fomitcheva, IV & Lopez, MM 1996, 'Mechanism of inhibition of the plasma membrane Ca2+-ATPase by barbiturates', Biochemistry, vol. 35, no. 3, pp. 900-905.
Kosk-Kosicka, Danuta ; Fomitcheva, Ioulia V ; Lopez, Maria M. / Mechanism of inhibition of the plasma membrane Ca2+-ATPase by barbiturates. In: Biochemistry. 1996 ; Vol. 35, No. 3. pp. 900-905.
@article{1216f996dbc74a94a6013860ad4f4e02,
title = "Mechanism of inhibition of the plasma membrane Ca2+-ATPase by barbiturates",
abstract = "We have demonstrated that sodium pentobarbital inhibited the activation of the human red blood cell plasma membrane Ca2+-ATPase produced by dimerization of enzyme monomers or by calmodulin binding to enzyme monomers. The effects of the barbiturate were dose-dependent. Both Vmax and Ca2+ affinity were reduced. The Ca2+-ATPase activity of the dimeric enzyme was distinctly less sensitive with respect to the effective inhibitory concentrations of pentobarbital and to the rate of onset of inhibition than was the calmodulin-dependent activation of enzyme monomers. Temperature dependence of the inhibition was in agreement with direct, nonpolar interactions of pentobarbital with a water-exposed nonpolar patch on the surface of this transmembrane protein. The barbiturate prevented the increase of intrinsic tryptophan fluorescence associated with substrate Ca2+ binding to the enzyme dimer. On the basis of the barbiturate effects we propose a model for the action of detergent-like compounds on the enzyme. They inhibit Ca2+-ATPase activity by binding to a nonpolar patch on the water-exposed dimerization surface of the enzyme monomer, part of which is also the binding site for calmodulin. The model assumes that their binding to the nonpolar patch on the monomer interferes with dimerization and weakens but does not prohibit calmodulin binding, whose activation of the enzyme is then submaximal. The model should be applicable to other proteins as the two activation pathways studied have been demonstrated for various enzymes.",
author = "Danuta Kosk-Kosicka and Fomitcheva, {Ioulia V} and Lopez, {Maria M.}",
year = "1996",
month = "1",
day = "23",
language = "English (US)",
volume = "35",
pages = "900--905",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Mechanism of inhibition of the plasma membrane Ca2+-ATPase by barbiturates

AU - Kosk-Kosicka, Danuta

AU - Fomitcheva, Ioulia V

AU - Lopez, Maria M.

PY - 1996/1/23

Y1 - 1996/1/23

N2 - We have demonstrated that sodium pentobarbital inhibited the activation of the human red blood cell plasma membrane Ca2+-ATPase produced by dimerization of enzyme monomers or by calmodulin binding to enzyme monomers. The effects of the barbiturate were dose-dependent. Both Vmax and Ca2+ affinity were reduced. The Ca2+-ATPase activity of the dimeric enzyme was distinctly less sensitive with respect to the effective inhibitory concentrations of pentobarbital and to the rate of onset of inhibition than was the calmodulin-dependent activation of enzyme monomers. Temperature dependence of the inhibition was in agreement with direct, nonpolar interactions of pentobarbital with a water-exposed nonpolar patch on the surface of this transmembrane protein. The barbiturate prevented the increase of intrinsic tryptophan fluorescence associated with substrate Ca2+ binding to the enzyme dimer. On the basis of the barbiturate effects we propose a model for the action of detergent-like compounds on the enzyme. They inhibit Ca2+-ATPase activity by binding to a nonpolar patch on the water-exposed dimerization surface of the enzyme monomer, part of which is also the binding site for calmodulin. The model assumes that their binding to the nonpolar patch on the monomer interferes with dimerization and weakens but does not prohibit calmodulin binding, whose activation of the enzyme is then submaximal. The model should be applicable to other proteins as the two activation pathways studied have been demonstrated for various enzymes.

AB - We have demonstrated that sodium pentobarbital inhibited the activation of the human red blood cell plasma membrane Ca2+-ATPase produced by dimerization of enzyme monomers or by calmodulin binding to enzyme monomers. The effects of the barbiturate were dose-dependent. Both Vmax and Ca2+ affinity were reduced. The Ca2+-ATPase activity of the dimeric enzyme was distinctly less sensitive with respect to the effective inhibitory concentrations of pentobarbital and to the rate of onset of inhibition than was the calmodulin-dependent activation of enzyme monomers. Temperature dependence of the inhibition was in agreement with direct, nonpolar interactions of pentobarbital with a water-exposed nonpolar patch on the surface of this transmembrane protein. The barbiturate prevented the increase of intrinsic tryptophan fluorescence associated with substrate Ca2+ binding to the enzyme dimer. On the basis of the barbiturate effects we propose a model for the action of detergent-like compounds on the enzyme. They inhibit Ca2+-ATPase activity by binding to a nonpolar patch on the water-exposed dimerization surface of the enzyme monomer, part of which is also the binding site for calmodulin. The model assumes that their binding to the nonpolar patch on the monomer interferes with dimerization and weakens but does not prohibit calmodulin binding, whose activation of the enzyme is then submaximal. The model should be applicable to other proteins as the two activation pathways studied have been demonstrated for various enzymes.

UR - http://www.scopus.com/inward/record.url?scp=0030064739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030064739&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 900

EP - 905

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 3

ER -